A common pattern is a 50 mg vial reconstituted with 2.0 mL bacteriostatic water, producing 25 mg/mL
Some GPs may incorrectly believe that only patients with a definite diagnosis of PA, those with a positive intrinsic factor antibody test, require treatment for life so seem to be using this as their treatment exclusion criteria
16 These differences may lead a clinician to choose a short-acting GLP- 1 receptor agonist for a patient with predominant postprandial hyperglycemia
This includes studies in nausea associated with medication use,10-15 the nausea of pregnancy,16-18 nausea in some disease states,19,20 nausea associated with surgery,21,22 and nausea associated with motion sickness.23 As another common adverse effect of GLP-1 agonist drug use, constipation can be addressed using fiber supplements
Maintaining appropriate environmental conditions can help ensure stability throughout the products shelf life